Use of Fluorescence in Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial
Journal of Urology - Netherlands
doi 10.1016/j.juro.2011.10.144
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2012
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)